Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 10/2000

01-10-2000

Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance

Authors: Mariko Kobayashi, Kazuaki Chayama, Yasuji Arase, Akihito Tsubota, Satoshi Saitoh, Yoshiyuki Suzuki, Masahiro Kobayashi, Naoya Murashima, Kenji Ikeda, Mika Hagiwara, Rie Hashimoto, Miki Nakagawa, Marie Matsuda, Hiromitsu Kumada

Published in: Journal of Gastroenterology | Issue 10/2000

Login to get access
Metadata
Title
Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance
Authors
Mariko Kobayashi
Kazuaki Chayama
Yasuji Arase
Akihito Tsubota
Satoshi Saitoh
Yoshiyuki Suzuki
Masahiro Kobayashi
Naoya Murashima
Kenji Ikeda
Mika Hagiwara
Rie Hashimoto
Miki Nakagawa
Marie Matsuda
Hiromitsu Kumada
Publication date
01-10-2000
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 10/2000
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s005350070034

Other articles of this Issue 10/2000

Journal of Gastroenterology 10/2000 Go to the issue

Review

DNA methylation and gastrointestinal malignancies: functional consequences and clinical implications

Editorial

Microsatellite instability meets gallbladder cancer

Editorial

Can determination of HBcAb titer be a surrogate for HBV DNA assay?

OriginalPaper

Microsatellite instability in gallbladder carcinoma: two independent genetic pathways of gallbladder carcinogenesis

OriginalPaper

The tight junction of pancreatic exocrine cells is a morphometrically dynamic structure altered by intraductal hypertension

Case report

Manifestation of cutaneous polyarteritis nodosa during interferon therapy for chronic hepatitis C associated with primary biliary cirrhosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits